Genetics Companies End Patent Dispute Over HPV Test

Law360, New York (January 13, 2006, 12:00 AM EST) -- Two feuding genetic testing product companies have ended a patent dispute over testing methods used to detect risk for the human papilloma virus, a common sexually transmitted infection that causes cervical cancer.

The settlement agreement comes about three months after Third Wave Technologies Inc. sued the Maryland-based Digene Corporation, seeking declaratory judgment supporting Third Wave's right to sell its HPV products.

In a press release on Friday, Digene stated that Third Wave had dismissed the suit without prejudice. Representatives from both companies could not be reached...
To view the full article, register now.